Human PANK2 activation kit by CRISPRa

CAT#: GA112799

PANK2 CRISPRa kit - CRISPR gene activation of human pantothenate kinase 2


  See Other Versions


Find the corresponding CRISPRi Inhibitor Kit

USD 1,657.00

2 Weeks*

Size
    • 1 kit

Product Images

Frequently bought together (2)
Anti-PANK2 mouse monoclonal antibody, clone OTI3H9 (formerly 3H9)
    • 100 ul

USD 478.00


PANK2 (Myc-DDK-tagged)-Human pantothenate kinase 2 (PANK2), nuclear gene encoding mitochondrial protein, transcript variant 1
    • 10 ug

USD 531.00

Other products for "PANK2"

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol PANK2
Locus ID 80025
Kit Components

GA112799G1, PANK2 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA112799G2, PANK2 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA112799G3, PANK2 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001324191, NM_001324192, NM_001324193, NM_024960, NM_153637, NM_153638, NM_153639, NM_153640, NM_153641, NR_136715
UniProt ID Q9BZ23
Synonyms C20orf48; HARP; HSS; NBIA1; PKAN
Summary This gene encodes a protein belonging to the pantothenate kinase family and is the only member of that family to be expressed in mitochondria. Pantothenate kinase is a key regulatory enzyme in the biosynthesis of coenzyme A (CoA) in bacteria and mammalian cells. It catalyzes the first committed step in the universal biosynthetic pathway leading to CoA and is itself subject to regulation through feedback inhibition by acyl CoA species. Mutations in this gene are associated with HARP syndrome and pantothenate kinase-associated neurodegeneration (PKAN), formerly Hallervorden-Spatz syndrome. Alternative splicing, involving the use of alternate first exons, results in multiple transcripts encoding different isoforms. [provided by RefSeq, Jul 2008]

Other Versions

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.